Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

AIN 457

Known as: AIN-457, AIN457 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Asthma stratification efforts have predominantly focused on subgroups defined by levels of circulating and sputum eosinophils. In… Expand
2016
2016
We have previously demonstrated that interleukin-17A (IL-17) producing T helper 17 cells are significantly elevated in blood and… Expand
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • figure 6
2014
2014
The family of interleukin 17 receptors (IL17Rs), subtypes IL17RA‐IL17RE, is targeted by the group of pro‐inflammatory IL17… Expand
2014
2014
Anti-cytokine autoantibodies have been widely reported to be present in human plasma, both in healthy subjects and in patients… Expand
2013
2013
To the Editor: Within the lung the T-helper cell interleukin (IL)-17 (also referred to as IL-17A) is recognised as one of the… Expand
2013
2013
Background Monoclonal antibodies (mAbs) comprise a large and important class of therapeutic biologicals with the potential for… Expand
Review
2011
Review
2011
Abstract Anti-cytokine therapies, including the anti-TNF-α antibody-based therapies, have largely transformed the management of… Expand
Highly Cited
2010
Highly Cited
2010
A human antibody to interleukin-17A is well tolerated and may be effective in the treatment of psoriasis, rheumatoid arthritis… Expand
2010
2010
  • V. Kuchroo
  • Nature Reviews Drug Discovery
  • 2010
  • Corpus ID: 27948583
monoclonal antibody AIN457, which is being developed by Novartis, has shown promising efficacy for the treatment of psoriasis… Expand
2010
2010
  • Emma J. Leah
  • Nature Reviews Rheumatology
  • 2010
  • Corpus ID: 45608624